Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,101–6,125 of 7,816 matching trials · page 245 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil NCT02006641 Placebo; Idalopirdine Runs in: Argentina; Brazil; Canada; Croatia; Czechia; Estonia; Fin... · 162 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 858 | H. Lundbeck A/S INDUSTRY |
2018-02-20 |
|
Assessing Neurovisual Function in Patients With Cognitive Impairment NCT03333096 Ocusweep test battery; Neuropsychological test battery Runs in: Finland · 1 site |
NA other |
UNKNOWN | 60 | Turku University Hospital OTHER_GOV |
2018-02-19 |
|
Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study NCT03411291 MRI, MR Spectroscopy, MR Perfusion Runs in: United States · 1 site |
NA other |
COMPLETED | 18 | Cedars-Sinai Medical Center OTHER |
2018-02-19 |
|
Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease NCT02471196 ORM-12741; ORM-12741; Placebo Runs in: Finland · 1 site |
PHASE2 other |
COMPLETED | 308 | Orion Corporation, Orion Pharma INDUSTRY |
2018-02-15 |
|
Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor NCT02006654 Placebo; Idalopirdine Runs in: Australia; Brazil; Czechia; Germany; Israel; Mexico; Serb... · 107 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 734 | H. Lundbeck A/S INDUSTRY |
2018-02-07 |
|
Trial of Carvedilol in Alzheimer's Disease NCT01354444 Carvedilol; Placebo Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 29 | Johns Hopkins University OTHER |
2018-02-06 |
|
Music Therapy in Alzheimer's Disease NCT02020356 Music therapy; Placebo Runs in: France · 7 sites |
NA other |
TERMINATED | 35 | University Hospital, Toulouse OTHER |
2018-02-06 |
|
A Pilot of the Feasibility of Using the Iron-Chelator Deferiprone on Mild Cognitive Impairment NCT02878538 Deferiprone; Placebo phase Runs in: United States · 1 site |
EARLY_PHASE1 other |
WITHDRAWN | 0 | The University of Texas Health Science Center at San Antonio OTHER |
2018-02-06 |
|
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease NCT00408525 donepezil Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 41 | Vanderbilt University OTHER |
2018-02-05 |
|
Alzheimer's Disease Acitretin Medication NCT01078168 Acitretin; Placebo Runs in: Germany · 2 sites |
PHASE2 other |
COMPLETED | 22 | K. Lieb OTHER |
2018-02-05 |
|
Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine NCT01380288 rivastigmine patch Runs in: South Korea · 16 sites |
NA symptomatic-cholinergic |
COMPLETED | 300 | Dong-A University OTHER |
2018-02-05 |
|
Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment NCT02211560 Phosphatidylserine; Placebo Runs in: Israel; United States · 15 sites |
NA other |
TERMINATED | 97 | Enzymotec INDUSTRY |
2018-02-05 |
|
Venlafaxine for Depression in Alzheimer's Disease (DIADs-3) NCT01609348 Placebo; Venlafaxine Runs in: United States · 2 sites |
NA other |
COMPLETED | 5 | Johns Hopkins University OTHER |
2018-01-31 |
|
Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration NCT02707458 Probucol Runs in: Canada · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 23 | Douglas Mental Health University Institute OTHER |
2018-01-31 |
|
Learning Oriented Physiotherapy - a New Approach NCT02194036 Learning Oriented Physiotherapy; Widely Recognized Psychiatric Treatment Runs in: Norway · 3 sites |
NA other |
COMPLETED | 81 | Helse Nord-Trøndelag HF OTHER |
2018-01-30 |
|
Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk NCT02832921 cognitive training by virtual reality; watching a scientific TV doc... Runs in: Israel · 1 site |
NA other |
UNKNOWN | 200 | Sheba Medical Center OTHER_GOV |
2018-01-26 |
|
Art Therapy and Music Reminiscence Activity in the Prevention of Cognitive Decline NCT02854085 Art Therapy; Music Reminiscence Activity Runs in: Singapore · 1 site |
NA other |
COMPLETED | 68 | National University of Singapore OTHER |
2018-01-26 |
|
Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder NCT02978742 Adaptive Recovery Record App; Standardized Coaching Runs in: Canada · 1 site |
NA other |
WITHDRAWN | 0 | Nova Scotia Health Authority OTHER |
2018-01-26 |
|
Cognitive Training to Promote Brain Health: Implementation and Engagement NCT03408509 Computerized cognitive training Runs in: Ireland · 1 site |
PHASE2 other |
UNKNOWN | 50 | Universidade Federal do Rio de Janeiro OTHER |
2018-01-26 |
|
Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease NCT01179373 TMS, H coil Runs in: Israel · 1 site |
PHASE2 other |
COMPLETED | 45 | Brainsway INDUSTRY |
2018-01-25 |
|
Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes NCT02140983 Liraglutide; Placebo Runs in: United States · 1 site |
PHASE1 GLP-1 |
COMPLETED | 41 | Stanford University OTHER |
2018-01-25 |
|
Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health Outcome NCT02854917 Runs in: United States · 1 site |
NA symptomatic-cholinergic |
COMPLETED | 20 | NYU Langone Health OTHER |
2018-01-25 |
|
Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's Disease NCT01847586 Paired Associative Stimulation; Paired Associative Stimulation-Control Runs in: Canada · 1 site |
NA other |
COMPLETED | 49 | Centre for Addiction and Mental Health OTHER |
2018-01-24 |
|
DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia NCT02103673 DAOIB; Placebo Runs in: Taiwan · 2 sites |
PHASE2 other |
COMPLETED | 90 | Chang Gung Memorial Hospital OTHER |
2018-01-24 |
|
NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment NCT02239003 DAOIB; Placebo Runs in: Taiwan · 1 site |
PHASE2 symptomatic-cholinergic |
COMPLETED | 24 | Chang Gung Memorial Hospital OTHER |
2018-01-24 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial